{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:39:31Z","timestamp":1790217571437,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1053\/j.ajkd.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T19:32:10Z","timestamp":1576783930000},"page":"513-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA"],"prefix":"10.1053","volume":"75","author":[{"given":"Aaron J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-5510","authenticated-orcid":false,"given":"Anthony","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2019.09.011_bib1","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/1097-0142(1971)28:5<1314::AID-CNCR2820280534>3.0.CO;2-D","article-title":"Renal toxicity in man treated with mitomycin C","volume":"28","author":"Liu","year":"1971","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.ajkd.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00873232","article-title":"Phase II trial of gemcitabine (2, 2\u2032-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas","volume":"12","author":"Casper","year":"1994","journal-title":"Invest New Drugs"},{"issue":"24","key":"10.1053\/j.ajkd.2019.09.011_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1053\/j.ajkd.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2019.09.011_bib5","first-page":"21","article-title":"Overexpression of either c-myc or c-erbB-2\/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis","volume":"3","author":"Guerin","year":"1987","journal-title":"Oncogene Res"},{"issue":"2","key":"10.1053\/j.ajkd.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0000000000000102","article-title":"Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies","volume":"38","author":"Ross","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5858\/2010-0048-OAR.1","article-title":"Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation","volume":"135","author":"Seethala","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"13","key":"10.1053\/j.ajkd.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/onc.2011.359","article-title":"Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts","volume":"31","author":"Perna","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"10.1053\/j.ajkd.2019.09.011_bib9","first-page":"1","article-title":"Strategies to inhibit Myc and their clinical applicability","volume":"5","author":"Whitfield","year":"2017","journal-title":"Front Cell Dev Biol"},{"issue":"7585","key":"10.1053\/j.ajkd.2019.09.011_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature16498","article-title":"FOXO1 couples metabolic activity and growth state in the vascular endothelium","volume":"529","author":"Wilhelm","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.ajkd.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"18","key":"10.1053\/j.ajkd.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/0008-5472.CAN-03-3176","article-title":"c-Myc interacts with hypoxia to induce angiogenesis in\u00a0vivo by a vascular endothelial growth factor-dependent mechanism","volume":"64","author":"Knies-Bamforth","year":"2004","journal-title":"Cancer Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619310674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619310674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:27:45Z","timestamp":1759462065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619310674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0272638619310674"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.09.011","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}